Posted Oct 4, 2018 4:44:55 PM
By Precision Coating
Leading Fluoropolymer and Anodic Coating Applicator Experiences Great Success at New England’s Largest Manufacturing Trade Show
Precision Coating Company, Inc. (PCCI), a subsidiary of Katahdin Industries Inc., exhibited at New England’s Design2Part show last week in West Marlborough, Massachusetts. Design2Part is New England’s largest contract manufacturing trade show and offered the unique opportunity for the region’s top manufacturers to meet face-to-face and share their latest innovative technologies. Representatives from PCCI displayed the company’s advanced aluminum coating technology for medical device components, including MICRALOX®, which produces a long lasting, virtually indestructible surface, that delivers dramatically superior chemical corrosion resistance and eliminates color-fading due to super-heated steam. Precision Coating’s Vice President of Sales & Marketing, David Dibiasio, noted after the show, “I was pleased with the turnout at the event. Attendance was up year over year 10 percent. The quality of the leads was very good including attendees from major OEMS. We generated interest in both our anodic coating and PTFE product offerings.”
For more information, visit www.precisioncoating.com, or call 1-855-876-0781.
About Precision Coating
Precision Coating seeks to improve health outcomes by enhancing the surfaces of medical devices and instruments worldwide through innovative, high-tolerance, and validated coating and printing processes in the interventional, orthopedic, endoscopic, and general surgical sectors. Precision Coating works with early-stage device innovators through major medical equipment manufacturers, deploying comprehensive solutions—from concept to commercialization—and offering flexible prototype work through high-volume coating application, finishing, and printing services. With facilities in Hudson, MA, Woonsocket, RI, and San Jose, Costa Rica, Precision Coating provides seamless supply chain support, fulfilling the exacting demands of medical manufacturing companies across an increasing number of strategic geographic hubs.